Community pharmacy & healthcare retailer Lloydspharmacy has today announced 120 head office redundancies following confirmation of a restructure of the business.
Last month, the specialist chain announced a restructure within its Coventry-based head office which was expected to affect IT, finance and HR departments, though the latest cuts are a reduction on the expected 200 job losses.
A Celesio UK spokesperson commented: “In April of this year, we announced proposals to restructure the head office functions of Lloydspharmacy and AAH Pharmaceuticals and a consultation exercise with staff affected was initiated.
“The consultation exercise has now ended. At the start of the consultation we had around 1100 people who could have been affected by the restructuring.”
At the beginning of the year, Managing Director Tony Page stepped down after just a year in the role while German parent company Celesio has introduced a new operational strategy in conjunction with sister company All About Health Pharmaceuticals (AAH).
The retailer would not be pressed on future plans for the struggling business, saying: “The appointment process has not concluded, however we expect to employ in future around 980 people in the new headquarters function.
“Of those leaving the business 60 at present have taken voluntary redundancy.”